Global Cell Line Development Market is expected to grow at a lucrative rate during the forecast period owing to the increasing development of stable and authentic cell lines, rising applications of cell culture techniques and growing prevalence of pandemic and high risk communicable diseases. Furthermore, expected increase in demand for clinical diagnostic techniques, and cell line development to develop in-vitro production of cell lines, and growing production of vaccines in the global population are also expected to fuel the market growth in the next seven years.
Full research report on Global Cell Line Development Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/cell-line-development-market
Increasing demand for monoclonal antibodies and growing demand of cell lines in academic research institutes, diagnostic laboratories, biopharmaceutical, and biotechnology industries for developing high-yielding and stable cell lines are expected to promote the growth of cell line development market during the forecast period. The expected patent expiration of important biologics and increasing research activities by research companies & institutes in order to develop effective and efficient cell lines. These factors are expected to further drive demand for cell line development market through to 2022.
Get more information on Global Cell Line Development Market or request for TOC of this research report at:
http://www.grandviewresearch.com/industry-analysis/cell-line-development-market/request-toc
Geographically, Europe, North America, Latin America, Asia Pacific, MEA are the key region of the market. In 2014, North America accounted for having the largest share of the global cell line development market in terms of revenue. This expected growth is attributed for by increasing application of cell culture and cell line techniques in cancer research, and increasing adoption of low cost cell cultures in diagnostic laboratories. However, Asia Pacific with emerging economies such India and China is expected to witness a significant growth rate in the next seven years owing to increasing number of cancer patients in the region, a number of investment opportunities in these immature markets, increasing government investment in the biotechnology and biopharmaceutical sector.
View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics
Furthermore, strengthening personal care and healthcare framework for treatment of high risk and infectious diseases and growing investment in diagnostic laboratories in the region are also expected to promote growth in the cell line development market. The key participants of the market include Lonza Group AG, Sigma-Aldrich Corporation, GE Healthcare, European Collection of cell Cultures (ECACC), Selexis SA, Corning Inc., American Type Culture Collection (ATCC), Sartorious AG and Wuxi AppTec Inc.
About Grand View Research
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
For more information, visit: http://www.grandviewresearch.com/
Media ContactCompany Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email:Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/cell-line-development-market
